Skip to main content
Top
Published in: BMC Neurology 1/2021

Open Access 01-12-2021 | Pneumonia | Research article

Decompressive craniectomy combined with mild hypothermia in patients with large hemispheric infarction: a randomized controlled trial

Authors: Linlin Fan, Yingying Su, Yan Zhang, Hong Ye, Weibi Chen, Gang Liu

Published in: BMC Neurology | Issue 1/2021

Login to get access

Abstract

Background

The effect of hypothermia on large hemispheric infarction (LHI) remains controversial. Our study aimed to explore the therapeutic outcomes of decompressive craniectomy (DC) combined with hypothermia on LHI.

Methods

Patients were randomly divided into three groups: the DC group, the DC plus head surface cooling (DCSC) group and the DC plus endovascular hypothermia (DCEH) group. The DC group was maintained normothermia. The DCSC group received 24-h ice cap on the head for 7 days. While the DCEH group were given endovascular hypothermia (34 °C). Mortality and modified Rankin Scale (mRS) score at 6 months were evaluated.

Results

Thirty-four patients were included in the study. Mortality of the DC, DCSC and DCEH groups at discharge were 22.2% (2/9), 0% (0/14) and 9.1% (1/11), respectively. However, it increased to 44.4% (4/9), 21.4% (3/14) and 45.5% (5/11) at 6 months, respectively (p = 0.367). Pneumonia (8 cases) was the leading cause of death after discharge. Twelve cases (35.3%) achieved good neurological outcome (mRS 0–3) at 6 months. The proportions of good neurological outcome in the DC, DCSC and DCEH groups were 22.2% (2/9 cases), 42.9% (6/14 cases) and 36.4% (4/11), respectively. The DCSC group seemed to have higher proportion of good outcomes, but there was no significant difference between groups (p = 0.598). Among survivors, endovascular hypothermia had a higher proportion of good outcome (DC group, 2/5 cases, 40.0%; DCSC group, 6/11 cases, 54.5%; DCEH group, 4/6 cases, 66.7%; p = 0.696). The incidence of complications in the DCEH group was higher than those of the DC and DCSC groups (18.9%, 12.0%, and 12.1%, respectively; p = 0.025).

Conclusions

There is still no evidence to confirm that hypothermia further reduces long-term mortality and improves neurological outcomes in LHI patients with DC. However, there is a trend to benefit survivors from hypothermia. A local cooling method may be a better option for DC patients, which has little impact on systematic complications.

Trial registration

Decompressive Hemicraniectomy Combined Hypothermia in Malignant Middle Cerebral Artery Infarct, ChiCTR-TRC-12002698. Registered 11 Oct 2012- Retrospectively registered, URL: http://​www.​chictr.​org.​cn/​showproj.​aspx?​proj=​6854.
Literature
1.
go back to reference Hacke W, Schwab S, Horn M, Spranger M, DeGeorgia M, von Kummer R. ‘Malignant’ middle cerebral artery territory infarction - clinical course and prognostic signs. Arch Neurol. 1996;53(4):309–15.CrossRef Hacke W, Schwab S, Horn M, Spranger M, DeGeorgia M, von Kummer R. ‘Malignant’ middle cerebral artery territory infarction - clinical course and prognostic signs. Arch Neurol. 1996;53(4):309–15.CrossRef
2.
go back to reference Juttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38(9):2518–25.CrossRef Juttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38(9):2518–25.CrossRef
3.
go back to reference Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL trial). Stroke. 2007;38(9):2506–17.CrossRef Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL trial). Stroke. 2007;38(9):2506–17.CrossRef
4.
go back to reference Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8(4):326–33.CrossRef Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8(4):326–33.CrossRef
5.
go back to reference Zhao J, Su YY, Zhang Y, Zhang YZ, Zhao R, Wang L, et al. Decompressive hemicraniectomy in malignant middle cerebral artery infarct: a randomized controlled trial enrolling patients up to 80 years old. Neurocrit Care. 2012;17(2):161–71.CrossRef Zhao J, Su YY, Zhang Y, Zhang YZ, Zhao R, Wang L, et al. Decompressive hemicraniectomy in malignant middle cerebral artery infarct: a randomized controlled trial enrolling patients up to 80 years old. Neurocrit Care. 2012;17(2):161–71.CrossRef
6.
go back to reference Geurts M, van der Worp HB, Kappelle LJ, Amelink GJ, Algra A, Hofmeijer J, et al. Surgical decompression for space-occupying cerebral infarction outcomes at 3 years in the randomized HAMLET trial. Stroke. 2013;44(9):2506–8.CrossRef Geurts M, van der Worp HB, Kappelle LJ, Amelink GJ, Algra A, Hofmeijer J, et al. Surgical decompression for space-occupying cerebral infarction outcomes at 3 years in the randomized HAMLET trial. Stroke. 2013;44(9):2506–8.CrossRef
7.
go back to reference Frank JI, Schumm LP, Wroblewski K, Chyatte D, Rosengart AJ, Kordeck C, et al. Hemicraniectomy and Durotomy upon deterioration from infarction-related swelling trial randomized pilot clinical trial. Stroke. 2014;45(3):781–7.CrossRef Frank JI, Schumm LP, Wroblewski K, Chyatte D, Rosengart AJ, Kordeck C, et al. Hemicraniectomy and Durotomy upon deterioration from infarction-related swelling trial randomized pilot clinical trial. Stroke. 2014;45(3):781–7.CrossRef
8.
go back to reference Su Y, Fan L, Zhang Y, Zhang Y, Ye H, Gao D, et al. Improved neurological outcome with mild hypothermia in surviving patients with massive cerebral hemispheric infarction. Stroke. 2016;47(2):457–63.CrossRef Su Y, Fan L, Zhang Y, Zhang Y, Ye H, Gao D, et al. Improved neurological outcome with mild hypothermia in surviving patients with massive cerebral hemispheric infarction. Stroke. 2016;47(2):457–63.CrossRef
9.
go back to reference Delhaye C, Mahmoudi M, Waksman R. Hypothermia therapy: neurological and cardiac benefits. J Am Coll Cardiol. 2012;59(3):197–210.CrossRef Delhaye C, Mahmoudi M, Waksman R. Hypothermia therapy: neurological and cardiac benefits. J Am Coll Cardiol. 2012;59(3):197–210.CrossRef
10.
go back to reference Erecinska M, Thoresen M, Silver IA. Effects of hypothermia on energy metabolism in mammalian central nervous system. J Cereb Blood Flow Metab. 2003;23(5):513–30.CrossRef Erecinska M, Thoresen M, Silver IA. Effects of hypothermia on energy metabolism in mammalian central nervous system. J Cereb Blood Flow Metab. 2003;23(5):513–30.CrossRef
11.
go back to reference Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009;37(7):S186–202.CrossRef Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009;37(7):S186–202.CrossRef
12.
go back to reference Han HS, Karabiyikoglu M, Kelly S, Sobel RA, Yenari MA. Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke. J Cereb Blood Flow Metab. 2003;23(5):589–98.CrossRef Han HS, Karabiyikoglu M, Kelly S, Sobel RA, Yenari MA. Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke. J Cereb Blood Flow Metab. 2003;23(5):589–98.CrossRef
13.
go back to reference Slikker W 3rd, Desai VG, Duhart H, Feuers R, Imam SZ. Hypothermia enhances bcl-2 expression and protects against oxidative stress-induced cell death in Chinese hamster ovary cells. Free Radic Biol Med. 2001;31(3):405–11.CrossRef Slikker W 3rd, Desai VG, Duhart H, Feuers R, Imam SZ. Hypothermia enhances bcl-2 expression and protects against oxidative stress-induced cell death in Chinese hamster ovary cells. Free Radic Biol Med. 2001;31(3):405–11.CrossRef
14.
go back to reference Chi OZ, Liu X, Weiss HR. Effects of mild hypothermia on blood-brain barrier disruption during isoflurane or pentobarbital anesthesia. Anesthesiology. 2001;95(4):933–8.CrossRef Chi OZ, Liu X, Weiss HR. Effects of mild hypothermia on blood-brain barrier disruption during isoflurane or pentobarbital anesthesia. Anesthesiology. 2001;95(4):933–8.CrossRef
15.
go back to reference Kamel H, Navi BB, Nakagawa K, Hemphill JC 3rd, Ko NU. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med. 2011;39(3):554–9.CrossRef Kamel H, Navi BB, Nakagawa K, Hemphill JC 3rd, Ko NU. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med. 2011;39(3):554–9.CrossRef
16.
go back to reference Chen H, Song Z, Dennis JA. Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury. Cochrane Database Syst Rev. 2020;1:CD010904.PubMed Chen H, Song Z, Dennis JA. Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury. Cochrane Database Syst Rev. 2020;1:CD010904.PubMed
17.
go back to reference Wu Z, Zhu SZ, Hu YF, Gu Y, Wang SN, Lin ZZ, et al. Glibenclamide enhances the effects of delayed hypothermia after experimental stroke in rats. Brain Res. 2016;1643:113–22.CrossRef Wu Z, Zhu SZ, Hu YF, Gu Y, Wang SN, Lin ZZ, et al. Glibenclamide enhances the effects of delayed hypothermia after experimental stroke in rats. Brain Res. 2016;1643:113–22.CrossRef
18.
go back to reference Simard JM, Woo SK, Tsymbalyuk N, Voloshyn O, Yurovsky V, Ivanova S, et al. Glibenclamide-10-h treatment window in a clinically relevant model of stroke. Transl Stroke Res. 2012;3(2):286–95.CrossRef Simard JM, Woo SK, Tsymbalyuk N, Voloshyn O, Yurovsky V, Ivanova S, et al. Glibenclamide-10-h treatment window in a clinically relevant model of stroke. Transl Stroke Res. 2012;3(2):286–95.CrossRef
19.
go back to reference Simard JM, Tsymbalyuk N, Tsymbalyuk O, Ivanova S, Yurovsky V, Gerzanich V. Glibenclamide is superior to Decompressive Craniectomy in a rat model of malignant stroke. Stroke. 2010;41(3):531–7.CrossRef Simard JM, Tsymbalyuk N, Tsymbalyuk O, Ivanova S, Yurovsky V, Gerzanich V. Glibenclamide is superior to Decompressive Craniectomy in a rat model of malignant stroke. Stroke. 2010;41(3):531–7.CrossRef
20.
go back to reference Chen ZY, Zhang XD, Liu CY. Outcomes of therapeutic hypothermia in patients treated with decompressive craniectomy for malignant middle cerebral artery infarction: a systematic review and meta-analysis. Clin Neurol Neurosurg. 2020;188:105569. Chen ZY, Zhang XD, Liu CY. Outcomes of therapeutic hypothermia in patients treated with decompressive craniectomy for malignant middle cerebral artery infarction: a systematic review and meta-analysis. Clin Neurol Neurosurg. 2020;188:105569.
21.
go back to reference Jayasekeran V, Singh S, Tyrrell P, Michou E, Jefferson S, Mistry S, et al. Adjunctive functional pharyngeal electrical stimulation reverses swallowing disability after brain lesions. Gastroenterology. 2010;138(5):1737–46.CrossRef Jayasekeran V, Singh S, Tyrrell P, Michou E, Jefferson S, Mistry S, et al. Adjunctive functional pharyngeal electrical stimulation reverses swallowing disability after brain lesions. Gastroenterology. 2010;138(5):1737–46.CrossRef
22.
go back to reference Hegland KW, Davenport PW, Brandimore AE, Singletary FF, Troche MS. Rehabilitation of swallowing and cough functions following stroke: an expiratory muscle strength training trial. Arch Phys Med Rehabil. 2016;97(8):1345–51.CrossRef Hegland KW, Davenport PW, Brandimore AE, Singletary FF, Troche MS. Rehabilitation of swallowing and cough functions following stroke: an expiratory muscle strength training trial. Arch Phys Med Rehabil. 2016;97(8):1345–51.CrossRef
23.
go back to reference Park J, Kim JH, Suk K, Han HS, Ohk B, Kim DG. Selective brain hypothermia augmenting Neuroprotective effects of Decompressive Craniectomy for permanent middle cerebral artery infarction in a rat model. World Neurosurg. 2019;121:e181–e90.CrossRef Park J, Kim JH, Suk K, Han HS, Ohk B, Kim DG. Selective brain hypothermia augmenting Neuroprotective effects of Decompressive Craniectomy for permanent middle cerebral artery infarction in a rat model. World Neurosurg. 2019;121:e181–e90.CrossRef
24.
go back to reference Els T, Oehm E, Voigt S, Klisch J, Hetzel A, Kassubek J. Safety and therapeutical benefit of hemicraniectomy combined with mild hypothermia in comparison with hemicraniectomy alone in patients with malignant ischemic stroke. Cerebrovasc Dis. 2006;21(1–2):79–85.CrossRef Els T, Oehm E, Voigt S, Klisch J, Hetzel A, Kassubek J. Safety and therapeutical benefit of hemicraniectomy combined with mild hypothermia in comparison with hemicraniectomy alone in patients with malignant ischemic stroke. Cerebrovasc Dis. 2006;21(1–2):79–85.CrossRef
25.
go back to reference Neugebauer H, Schneider H, Bosel J, Hobohm C, Poli S, Kollmar R, et al. Outcomes of hypothermia in addition to Decompressive Hemicraniectomy in treatment of malignant middle cerebral artery stroke: a randomized clinical trial. JAMA Neurol. 2019;76(5):571–9.CrossRef Neugebauer H, Schneider H, Bosel J, Hobohm C, Poli S, Kollmar R, et al. Outcomes of hypothermia in addition to Decompressive Hemicraniectomy in treatment of malignant middle cerebral artery stroke: a randomized clinical trial. JAMA Neurol. 2019;76(5):571–9.CrossRef
26.
go back to reference Engrand N, Mazighi M, Dinkelacker V. Hypothermia after Decompressive Hemicraniectomy in treatment of malignant middle cerebral artery stroke: comment on the randomized clinical trial. Crit Care. 2019;23(1):164.CrossRef Engrand N, Mazighi M, Dinkelacker V. Hypothermia after Decompressive Hemicraniectomy in treatment of malignant middle cerebral artery stroke: comment on the randomized clinical trial. Crit Care. 2019;23(1):164.CrossRef
27.
go back to reference Park HS, Choi JH. Safety and efficacy of hypothermia (34 degrees C) after Hemicraniectomy for malignant MCA infarction. J Korean Neurosurg Soc. 2018;61(2):267–76.CrossRef Park HS, Choi JH. Safety and efficacy of hypothermia (34 degrees C) after Hemicraniectomy for malignant MCA infarction. J Korean Neurosurg Soc. 2018;61(2):267–76.CrossRef
Metadata
Title
Decompressive craniectomy combined with mild hypothermia in patients with large hemispheric infarction: a randomized controlled trial
Authors
Linlin Fan
Yingying Su
Yan Zhang
Hong Ye
Weibi Chen
Gang Liu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-021-02142-7

Other articles of this Issue 1/2021

BMC Neurology 1/2021 Go to the issue